influenza-COVID-19 combination — Topline data
2027
Novavax intends to enter the clinic with at least one program as early as 2027.Source filing
NVAX biotech catalysts & pipeline
NOVAVAX INC · Data as of 2026-09-08
Upcoming catalysts
COVID-19 Vaccine (Nuvaxovid™) — Regulatory decision
mid-2027
Completion of manufacturing technology transfer to Sanofi expected in mid-2027 and would trigger a $75 million milestone payment to NovavaxSource filing